Literature DB >> 57449

Place of azathioprine for Crohn's disease.

B N Brooke, D R Cave, D W King.   

Abstract

The clinical effects of azathioprine have been compared with those of corticosteroids in a group of 112 patients who have come under the care of a single unit between 1963 and 1975. There is no clear evidence that azathioprine alters the course of the disease in the long term; it is of value in obtaining a remission, particularly when the disease affects the large intestine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57449     DOI: 10.1016/s0140-6736(76)92218-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

Review 1.  Management of perianal Crohn's disease.

Authors:  A Allan; M R Keighley
Journal:  World J Surg       Date:  1988-04       Impact factor: 3.352

2.  Azathioprine has a very limited role in the treatment of Crohn's disease.

Authors:  J W Singleton
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

3.  Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease.

Authors:  J E Lennard-Jones
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

4.  Perianal Crohn's disease.

Authors:  J Alexander-Williams; P Buchmann
Journal:  World J Surg       Date:  1980       Impact factor: 3.352

5.  Crohn disease. Newer aspects of etiology, diagnosis and therapy.

Authors: 
Journal:  West J Med       Date:  1978-05

Review 6.  Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

Authors:  Nilesh Chande; Cassandra M Townsend; Claire E Parker; John K MacDonald
Journal:  Cochrane Database Syst Rev       Date:  2016-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.